Genomic Profiling of Sarcomas: A Promising Weapon in the Therapeutic Arsenal

Sarcomas are rare malignant mesenchymal neoplasms, and the knowledge of tumor biology and genomics is scarce. Chemotherapy is the standard of care in advanced disease, with poor outcomes. Identifying actionable genomic alterations may offer effective salvage therapeutic options when previous lines h...

Descripción completa

Detalles Bibliográficos
Autores principales: Lopes-Brás, Raquel, Lopez-Presa, Dolores, Esperança-Martins, Miguel, Melo-Alvim, Cecília, Gallego, Lina, Costa, Luís, Fernandes, Isabel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693140/
https://www.ncbi.nlm.nih.gov/pubmed/36430703
http://dx.doi.org/10.3390/ijms232214227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693140/
https://www.ncbi.nlm.nih.gov/pubmed/36430703
http://dx.doi.org/10.3390/ijms232214227

Ejemplares similares